Question 1

What is the catalog number for RPS15AP38 CRISPR Knock Out 293T Cell Line (Human)?

Accepted Answer

The catalog number for RPS15AP38 CRISPR Knock Out 293T Cell Line (Human) is 42137141.

Question 2

What sizes are available for RPS15AP38 CRISPR Knock Out 293T Cell Line (Human)?

Accepted Answer

RPS15AP38 CRISPR Knock Out 293T Cell Line (Human) is available in the following size(s): 1x 10^6 Cells / 1.0 mL.

Question 3

Is RPS15AP38 CRISPR Knock Out 293T Cell Line (Human) in stock?

Accepted Answer

RPS15AP38 CRISPR Knock Out 293T Cell Line (Human) is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

Is this kit compatible with automated liquid handling platforms?

Accepted Answer

Automation compatibility varies by kit and isn’t always listed on the datasheet. Contact our technical support team with details of your platform so we can confirm with the manufacturer.

Question 5

What applications has this product been validated for?

Accepted Answer

Validated applications such as WB, ELISA, IHC, ICC, or FC are listed on the product datasheet. If you need application-specific validation data before ordering, contact our technical support team with the catalogue number.

Question 6

How do I reconstitute this lyophilized product?

Accepted Answer

Reconstitution instructions, including the recommended diluent and final concentration, are provided on the datasheet. Aliquot immediately after reconstitution to avoid repeated freeze-thaw cycles.

RPS15AP38 CRISPR Knock Out 293T Cell Line (Human)

Product Specifications

Gene Name

Accession Number

Reactivity

Shipping Conditions

Storage Conditions

Frequently Asked Questions

Explore Other Products

Thyroid Stimulating Hormone, beta (TSH beta) (Pituitary Marker) (TSHb/1317), CF740 conjugate, 0.1mg/mL

Bcl-2 (100/D5 + 124), CF594 conjugate, 0.1mg/mL

CD45RA (PTPRC/1148), CF594 conjugate, 0.1mg/mL

Human Kappa Light Chain / IGKC (B-Cell Marker) (rKLC709), CF640R conjugate, 0.1mg/mL

TIGIT / VSTM3 / VSIG9 (Immune Checkpoint for Cancer) (TIGIT/3017), CF640R conjugate, 0.1mg/mL

PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746), CF594 conjugate, 0.1mg/mL